Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 374.0 | 41 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 323.0 | 41 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 440.5 | 72 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 314.0 | 50 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 463.5 | 64 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 243.5 | 74 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 314.5 | 60 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 404.0 | 57 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 310.5 | 64 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 368.5 | 62 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 490.0 | 77 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 508.5 | 60 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 658.0 | 51 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 648.0 | 53 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 597.0 | 43 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 460.0 | 38 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 531.0 | 43 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 393.0 | 40 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 328.0 | 64 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 312.0 | 52 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 682.0 | 45 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 660.0 | 53 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 368.5 | 50 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 393.5 | 48 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 540.0 | 42 |